You May Not Be Receiving the Most Accurate Information About Autism Drugs


By Molly Grady

New research claims there's a bias when it comes to publishing studies about autism drugs.

An article in Pediatrics finds that positive results on serotonin receptor inhibitors, or SRIs are more likely to be published.

The drugs are used to treat repetitive behaviors, which are a hallmark of autism.

The authors found there were several unpublished studies that didn't show a significant benefit.

The authors say the results of all completed trials should be disclosed... not just the positive ones.

What's Trending

This content requires the latest Adobe Flash Player and a browser with JavaScript enabled. Click here for a free download of the latest Adobe Flash Player.

What's onFull Schedule

Hot Video From AP

AP Video